Oragenics Interest Income from 2010 to 2026

OGEN Stock  USD 0.85  0.00  0.000002%   
Oragenics Interest Income yearly trend continues to be very stable with very little volatility. Interest Income is likely to drop to about 50.1 K. Interest Income is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. View All Fundamentals
 
Interest Income  
First Reported
2019-03-31
Previous Quarter
16.8 K
Current Value
68.1 K
Quarterly Volatility
27.6 K
 
Covid
Check Oragenics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oragenics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 33.3 K, Interest Expense of 25.5 K or Selling General Administrative of 4.3 M, as well as many indicators such as Price To Sales Ratio of 2.9 K, Dividend Yield of 4.0E-4 or Days Sales Outstanding of 7.16. Oragenics financial statements analysis is a perfect complement when working with Oragenics Valuation or Volatility modules.
  
Build AI portfolio with Oragenics Stock
Check out the analysis of Oragenics Correlation against competitors.
To learn how to invest in Oragenics Stock, please use our How to Invest in Oragenics guide.

Latest Oragenics' Interest Income Growth Pattern

Below is the plot of the Interest Income of Oragenics over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. Oragenics' Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Oragenics' overall financial position and show how it may be relating to other accounts over time.
Interest Income10 Years Trend
Pretty Stable
   Interest Income   
       Timeline  

Oragenics Interest Income Regression Statistics

Arithmetic Mean86,895
Geometric Mean66,044
Coefficient Of Variation90.15
Mean Deviation51,339
Median55,290
Standard Deviation78,340
Sample Variance6.1B
Range309.8K
R-Value0.25
Mean Square Error6.1B
R-Squared0.06
Significance0.33
Slope3,908
Total Sum of Squares98.2B

Oragenics Interest Income History

202650.1 K
202552.8 K
202445.9 K
2023238.8 K
2022135.9 K
202175.8 K
202089.3 K

Other Fundumenentals of Oragenics

Oragenics Interest Income component correlations

0.98-0.97-0.05-0.16-0.211.00.7-0.02-0.11-0.25-0.29-0.230.620.290.040.860.920.32
0.98-1.0-0.07-0.18-0.420.980.68-0.03-0.24-0.45-0.46-0.190.660.320.040.810.860.29
-0.97-1.00.060.170.42-0.97-0.720.050.220.460.450.19-0.66-0.31-0.03-0.8-0.85-0.3
-0.05-0.070.06-0.670.12-0.03-0.05-0.780.540.250.530.52-0.66-0.92-0.91-0.310.030.8
-0.16-0.180.17-0.670.14-0.18-0.140.51-0.310.01-0.19-0.340.40.520.610.07-0.19-0.65
-0.21-0.420.420.120.14-0.22-0.150.060.610.980.84-0.11-0.37-0.24-0.04-0.04-0.030.04
1.00.98-0.97-0.03-0.18-0.220.7-0.03-0.1-0.26-0.29-0.220.610.280.020.850.910.32
0.70.68-0.72-0.05-0.14-0.150.7-0.03-0.15-0.19-0.24-0.170.480.240.080.640.710.29
-0.02-0.030.05-0.780.510.06-0.03-0.03-0.31-0.01-0.2-0.230.550.680.870.33-0.02-0.85
-0.11-0.240.220.54-0.310.61-0.1-0.15-0.310.650.81-0.06-0.35-0.61-0.47-0.31-0.150.34
-0.25-0.450.460.250.010.98-0.26-0.19-0.010.650.890.01-0.48-0.38-0.15-0.1-0.050.1
-0.29-0.460.450.53-0.190.84-0.29-0.24-0.20.810.890.22-0.6-0.64-0.37-0.24-0.110.27
-0.23-0.190.190.52-0.34-0.11-0.22-0.17-0.23-0.060.010.22-0.58-0.49-0.25-0.17-0.080.18
0.620.66-0.66-0.660.4-0.370.610.480.55-0.35-0.48-0.6-0.580.760.60.620.42-0.4
0.290.32-0.31-0.920.52-0.240.280.240.68-0.61-0.38-0.64-0.490.760.880.480.2-0.59
0.040.04-0.03-0.910.61-0.040.020.080.87-0.47-0.15-0.37-0.250.60.880.340.0-0.82
0.860.81-0.8-0.310.07-0.040.850.640.33-0.31-0.1-0.24-0.170.620.480.340.920.0
0.920.86-0.850.03-0.19-0.030.910.71-0.02-0.15-0.05-0.11-0.080.420.20.00.920.38
0.320.29-0.30.8-0.650.040.320.29-0.850.340.10.270.18-0.4-0.59-0.820.00.38
Click cells to compare fundamentals

About Oragenics Financial Statements

Oragenics investors utilize fundamental indicators, such as Interest Income, to predict how Oragenics Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Interest Income52.8 K50.1 K
Net Interest Income18.5 K17.6 K

Pair Trading with Oragenics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Oragenics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oragenics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Oragenics Stock

  0.91LIPO Lipella PharmaceuticalsPairCorr

Moving against Oragenics Stock

  0.89JNJ Johnson JohnsonPairCorr
  0.88DD Dupont De NemoursPairCorr
  0.84CSCO Cisco SystemsPairCorr
  0.83ATI Allegheny TechnologiesPairCorr
  0.83WSFS WSFS FinancialPairCorr
The ability to find closely correlated positions to Oragenics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Oragenics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Oragenics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Oragenics to buy it.
The correlation of Oragenics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Oragenics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Oragenics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Oragenics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Oragenics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oragenics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oragenics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oragenics Stock:
Check out the analysis of Oragenics Correlation against competitors.
To learn how to invest in Oragenics Stock, please use our How to Invest in Oragenics guide.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oragenics. If investors know Oragenics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oragenics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
48.21
Quarterly Revenue Growth
(0.91)
Return On Assets
(0.71)
Return On Equity
(1.69)
The market value of Oragenics is measured differently than its book value, which is the value of Oragenics that is recorded on the company's balance sheet. Investors also form their own opinion of Oragenics' value that differs from its market value or its book value, called intrinsic value, which is Oragenics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oragenics' market value can be influenced by many factors that don't directly affect Oragenics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oragenics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oragenics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oragenics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.